Elevai Labs, Inc.

The momentum for this stock is not very good. Elevai Labs, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Elevai Labs, Inc..

News

Elevai Labs subsidiary announces results from E-series exosome technology

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications

Globe Newswire Case Studies Highlight Potential of Elevai Exosome Technology in Melasma Care When Used with Laser Therapy. Early Results Show Synergistic Effects of Elevai Exosomes and Laser Treatments for...\n more…

Elevai Labs files for 25M stock offering

SeekingAlpha.com: All News Elevai Labs (ELAB) files prospectus for offering up to 25M shares of common stock, Series A warrants, and Series B warrants.\n more…

Elevai Labs files to sell 25M shares of common stock, warrants

Elevai Labs Inc. (ELAB) National Hair Loss Aesthetics Slide Presentation

SeekingAlpha Elevai Labs Inc. (ELAB) National Hair Loss Aesthetics Slide Presentation...\n more…